
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, discusses why every patient with glioblastoma should have their tumor profiled, and what patients can ask their care team.
Today, the Food and Drug Administration approved a new painkiller called Onsolis. It's an absorbable film that you stick to the inside of your cheek and it delivers a potent dose of fentanyl. The FDA approved the opioid pain reliever specifically for breakthrough -- severe, but short-lived -- pain that patients experience despite round-the-clock use of other pain medications. There's also some pretty tough restrictions on getting access to Onsolis -- patients have to be counseled by phone before they receive the drug, which is then sent directly to the patient's home.Check out the approval and distribution details from the






